EFNB2 p.Arg277Cys
c.829C>T · VCV3507040
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4403 | ambiguous |
|---|---|---|
| REVEL | 0.527 | indeterminate |
| SaProt | LLR -7.81 | tolerated |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 9.9 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.73 | unconstrained · MANE · 2,723 bp · p 2.4e-05 · regional, not allelic |
| Overall | ||
| CADD | 25.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00833% | 12,001 |
| African / African-American | 0.00267% | 37,462 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,488 |
| European (non-Finnish) | 0.00144% | 69,415 |
| South Asian | 0.0011% | 91,088 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EFNB2
- Protein
- p.Arg277Cys
- Coding
- c.829C>T
- MANE Select
- NM_004093
- Type
- single nucleotide variant
- Location
- chr13:106493213 (GRCh38)
- Gene constraint
- LOEUF 0.261 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 71.60 · 10 PDB
- Residue 277
- a modified residue (omega-n-methylarginine)
Similar variants
- EFNB2 p.Tyr73Ter Likely pathogenic ★ same type
- EFNB2 p.Ala157Thr Uncertain significance ★ ⚠ same type
- EFNB2 p.Ala296Ser Uncertain significance ★ ⚠ same type
- EFNB2 p.Arg156Lys Uncertain significance ★ ⚠ same type
- EFNB2 p.Arg182His Uncertain significance ★ ⚠ same type
- EFNB2 p.Arg253Gln Uncertain significance ★ ⚠ same type
- EFNB2 p.Arg253Trp Uncertain significance ★ ⚠ same type
- EFNB2 p.Arg5Gly Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/efnb2-p-arg277cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown